Search

Search Constraints

You searched for: Author/Creator Connell, Carol A.

Search Results

2. FRI0162 BASELINE CHARACTERISTICS AND OUTCOMES IN PATIENTS WITH ANAEMIA IN CLINICAL STUDIES OF TOFACITINIB IN RHEUMATOID ARTHRITIS. (June 2019)

3. OP0028 POST-APPROVAL COMPARATIVE SAFETY STUDY OF TOFACITINIB AND BIOLOGIC DMARDS: FIVE–YEAR RESULTS FROM A US-BASED RHEUMATOID ARTHRITIS REGISTRY. (June 2019)

4. Postapproval Comparative Safety Study of Tofacitinib and Biological Disease‐Modifying Antirheumatic Drugs: 5‐Year Results from a United States–Based Rheumatoid Arthritis Registry. Issue 3 (11th February 2021)

5. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study. Issue 3 (25th February 2013)

6. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study12. Issue 3 (25th February 2013)

7. Tofacitinib (CP‐690, 550) in patients with rheumatoid arthritis receiving methotrexate: Twelve‐month data from a twenty‐four–month phase III randomized radiographic study12. Issue 3 (25th February 2013)

8. Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study. Issue 6 (24th April 2019)